or Try an Advanced Search...

    Protein Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    ALLR F Allarity Therapeutics, Inc. 4.92
    ACLX D Arcellx, Inc. -5.67
    AVBP F ArriVent BioPharma, Inc. -1.61
    BPMC A Blueprint Medicines Corporation -1.51
    BBIO F BridgeBio Pharma, Inc. 1.29
    COGT C Cogent Biosciences, Inc. -4.55
    CRIS B Curis, Inc. -4.78
    DAWN B Day One Biopharmaceuticals, Inc. -2.32
    DCPH A Deciphera Pharmaceuticals, Inc. -0.04
    ELVN B Enliven Therapeutics, Inc. -1.97
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Solid Tumors Acute Myeloid Leukemia Biotechnology Clinical Medicine Lymphoma Multiple Myeloma Myelodysplastic Syndrome Phosphoinositide 3 Kinase Inhibitor Advanced Non Small Cell Lung Cancer Antibody Drug Conjugate Biopharmaceutical Blastoma Breast Cancer Cancer Cell Cancer Therapeutics Cancer Treatment Carcinoma Chronic Myeloid Leukemia Disease

    Related ETFs - A few ETFs which own one or more of the above listed Protein Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 2.28
    CNCR D Loncar Cancer Immunotherapy ETF 2.07
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.07
    SBIO D ALPS Medical Breakthroughs ETF 1.78
    XBI D SPDR S&P Biotech ETF 1.38
    View all Protein Kinase Inhibitor ETFs...
    Compare ETFs
    Compare BBC to SBIO Compare IDNA to CNCR Compare IDNA to XBI

        Protein Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 10 ACLX Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
        May 10 DCPH Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
        May 10 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
        May 10 CRIS Curis to Present Updated Data from the TakeAim Leukemia Study
        May 10 ACLX Arcellx GAAP EPS of -$0.14, revenue of $39.3M
        May 10 ACLX Kite and Arcellx prepare to launch Phase III multiple myeloma trial
        May 9 ACLX Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 ACLX Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ACLX Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ACLX Arcellx Provides First Quarter 2024 Financial Results
        May 8 CRIS Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
        May 8 AVBP ArriVent BioPharma reports Q1 results
        May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
        May 8 CRIS Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript
        May 7 ACLX Arcellx to Participate in Two Upcoming Investor Conferences
        May 7 COGT Cogent Biosciences EPS of -$0.62 misses by $0.11
        May 7 ALLR All You Need to Know About Allarity Therapeutics, Inc. (ALLR) Rating Upgrade to Buy
        May 7 ALLR Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
        May 7 CRIS Curis GAAP EPS of -$2.05, revenue of $2.1M
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Solid Tumors Acute Myeloid Leukemia Biotechnology Clinical Medicine Lymphoma Multiple Myeloma Myelodysplastic Syndrome Phosphoinositide 3 Kinase Inhibitor Advanced Non Small Cell Lung Cancer Antibody Drug Conjugate Biopharmaceutical Blastoma Breast Cancer Cancer Cell Cancer Therapeutics Cancer Treatment Carcinoma Chronic Myeloid Leukemia Disease
        Protein Kinase Inhibitor

        Protein kinase inhibitors are drugs that block the activity of one or more protein kinases. Protein kinases are enzymes that add phosphate groups to proteins, which can alter their activity and function. Protein kinase inhibitors are used to treat a variety of diseases, including cancer, inflammation, and autoimmune disorders.

        Browse All Tags